CL
TEVA icon

CSS LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

CSS LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$307K – 1138
2025
Q1 		$307K Buy
+20,000
New +$357K 0.02% 624
2018
Q2 		– Sell
-40,000
Closed -$684K – 557
2018
Q1 		$684K Sell
40,000
-20,900
-34% -$408K 0.03% 268
2017
Q4 		$1.15M Buy
+60,900
New +$916K 0.06% 213

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CSS LLC's TEVA Position: Q2 2026 in Review

CSS LLC held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 27,070 shares worth $917K. The position accounts for 0.04% of the portfolio, ranked #375.

CSS LLC first reported a position in TEVA in Q4 2018 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • CSS LLC held 27,070 shares of Teva Pharmaceutical Industries Limited worth $917K as of Q2 2026.
  • CSS LLC left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.04% of CSS LLC's portfolio in Q2 2026, its #375 holding.
  • CSS LLC first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and has held it in 9 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.